Operating Lease, Right-of-Use Asset of ADC Therapeutics SA from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: ADC Therapeutics SA quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
ADC Therapeutics SA Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,393,000, a 85% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ADC Therapeutics SA Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$1,393,000	-$7,795,000	-85%	30 Sep 2025	10-Q	10 Nov 2025	2025	Q3
Q2 2025	$1,488,000	-$8,197,000	-85%	30 Jun 2025	10-Q	12 Aug 2025	2025	Q2
Q1 2025	$8,231,000	-$1,828,000	-18%	31 Mar 2025	10-Q	14 May 2025	2025	Q1
Q4 2024	$8,354,000	-$2,157,000	-21%	31 Dec 2024	10-Q	10 Nov 2025	2025	Q3
Q3 2024	$9,188,000			30 Sep 2024	10-Q	07 Nov 2024	2024	Q3
Q2 2024	$9,685,000			30 Jun 2024	10-Q	06 Aug 2024	2024	Q2
Q1 2024	$10,059,000			31 Mar 2024	10-Q	06 May 2024	2024	Q1
Q4 2023	$10,511,000	+$3,606,000	+52%	31 Dec 2023	10-K	27 Mar 2025	2024	FY
Q4 2022	$6,905,000			31 Dec 2022	10-K	13 Mar 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.